Sign up to save your podcasts
Or
Share E165 Jillian Janaczek: Curiosity is More Durable than Certainty
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
E165 Jillian Janaczek: Curiosity is More Durable than Certainty
As CEO of Porter Novelli, Jillian Janaczek manages talent and operations of the strategic communications company globally, nurturing key client relationships, and driving business growth across Health, Corporate + Brand, Food + Ag + Nutrition, Purpose + Impact, Tech, and Government, as well as strategic services. She is part of OPRG’s (Omnicom PR Group’s) global leadership team.
Before Porter Novelli, Janaczek was President, BCW New York, spearheading the firm’s largest market and managing Fortune 500 clients. She sat on BCW’s Global Board and was Chair, Client Risk Committee.
Earlier in her career, Janaczek was Managing Director of Healthcare at Cohn & Wolfe. Her background includes extensive work with prescription medications and Rx to OTC switches. She has worked closely with leading companies such as AbbVie, GlaxoSmithKline, Gilead, Johnson & Johnson, Merck, Novartis and Novo Nordisk, among many others, providing strategic counsel for U.S. and Global programs. She expanded her role with Novartis Pharma AG by working in-house as Global Brand Manager in Basel, Switzerland.
View all episodes
By Shorty AwardsAs CEO of Porter Novelli, Jillian Janaczek manages talent and operations of the strategic communications company globally, nurturing key client relationships, and driving business growth across Health, Corporate + Brand, Food + Ag + Nutrition, Purpose + Impact, Tech, and Government, as well as strategic services. She is part of OPRG’s (Omnicom PR Group’s) global leadership team.
Before Porter Novelli, Janaczek was President, BCW New York, spearheading the firm’s largest market and managing Fortune 500 clients. She sat on BCW’s Global Board and was Chair, Client Risk Committee.
Earlier in her career, Janaczek was Managing Director of Healthcare at Cohn & Wolfe. Her background includes extensive work with prescription medications and Rx to OTC switches. She has worked closely with leading companies such as AbbVie, GlaxoSmithKline, Gilead, Johnson & Johnson, Merck, Novartis and Novo Nordisk, among many others, providing strategic counsel for U.S. and Global programs. She expanded her role with Novartis Pharma AG by working in-house as Global Brand Manager in Basel, Switzerland.